logo
Santova Full Year 2025 Earnings: EPS: R1.15 (vs R1.12 in FY 2024)

Santova Full Year 2025 Earnings: EPS: R1.15 (vs R1.12 in FY 2024)

Yahoo29-05-2025
Revenue: R648.9m (down 1.3% from FY 2024).
Net income: R148.1m (flat on FY 2024).
Profit margin: 23% (in line with FY 2024).
EPS: R1.15 (up from R1.12 in FY 2024).
This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Santova shares are up 1.2% from a week ago.
Before you take the next step you should know about the 1 warning sign for Santova that we have uncovered.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Bellevue Group First Half 2025 Earnings: EPS: CHF0.014 (vs CHF0.56 in 1H 2024)
Bellevue Group First Half 2025 Earnings: EPS: CHF0.014 (vs CHF0.56 in 1H 2024)

Yahoo

time6 hours ago

  • Yahoo

Bellevue Group First Half 2025 Earnings: EPS: CHF0.014 (vs CHF0.56 in 1H 2024)

Bellevue Group (VTX:BBN) First Half 2025 Results Key Financial Results Revenue: CHF25.2m (down 32% from 1H 2024). Net income: CHF185.0k (down 98% from 1H 2024). Profit margin: 0.7% (down from 20% in 1H 2024). The decrease in margin was driven by lower revenue. EPS: CHF0.014 (down from CHF0.56 in 1H 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Bellevue Group shares are down 3.4% from a week ago. Risk Analysis Don't forget that there may still be risks. For instance, we've identified 4 warning signs for Bellevue Group (2 are a bit concerning) you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

WCE Holdings Berhad Full Year 2025 Earnings: RM0.047 loss per share (vs RM0.045 loss in FY 2024)
WCE Holdings Berhad Full Year 2025 Earnings: RM0.047 loss per share (vs RM0.045 loss in FY 2024)

Yahoo

time11 hours ago

  • Yahoo

WCE Holdings Berhad Full Year 2025 Earnings: RM0.047 loss per share (vs RM0.045 loss in FY 2024)

WCE Holdings Berhad (KLSE:WCEHB) Full Year 2025 Results Key Financial Results Revenue: RM629.1m (up 2.3% from FY 2024). Net loss: RM147.0m (loss widened by 9.9% from FY 2024). RM0.047 loss per share (further deteriorated from RM0.045 loss in FY 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period The primary driver behind last 12 months revenue was the Concession segment contributing a total revenue of RM619.6m (98% of total revenue). Notably, cost of sales worth RM548.6m amounted to 87% of total revenue thereby underscoring the impact on earnings. The most substantial expense, totaling RM226.6m were related to Non-Operating costs. This indicates that a significant portion of the company's costs is related to non-core activities. Explore how WCEHB's revenue and expenses shape its earnings. WCE Holdings Berhad's share price is broadly unchanged from a week ago. Risk Analysis Before we wrap up, we've discovered 2 warning signs for WCE Holdings Berhad that you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio

Power Root Berhad Full Year 2025 Earnings: Misses Expectations
Power Root Berhad Full Year 2025 Earnings: Misses Expectations

Yahoo

time11 hours ago

  • Yahoo

Power Root Berhad Full Year 2025 Earnings: Misses Expectations

Power Root Berhad (KLSE:PWROOT) Full Year 2025 Results Key Financial Results Revenue: RM413.0m (flat on FY 2024). Net income: RM32.0m (down 23% from FY 2024). Profit margin: 7.7% (down from 10.0% in FY 2024). EPS: RM0.072 (down from RM0.091 in FY 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Power Root Berhad Revenues and Earnings Miss Expectations Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) also missed analyst estimates by 8.1%. Looking ahead, revenue is forecast to grow 6.3% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Beverage industry in Malaysia. Performance of the Malaysian Beverage industry. The company's share price is broadly unchanged from a week ago. Risk Analysis You should learn about the 2 warning signs we've spotted with Power Root Berhad. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store